Literature DB >> 11194248

Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.

C Weyer1, P A Tataranni, C Bogardus, R E Pratley.   

Abstract

OBJECTIVE: Although prospective studies indicate that insulin resistance and insulin secretory dysfunction predict type 2 diabetes, they provide limited information on the relative contributions of both abnormalities to worsening glucose tolerance at different developmental stages of the disease. We therefore assessed the predictive effect of insulin resistance and insulin secretory dysfunction separately for the progression from normal glucose tolerance (NGT) to impaired glucose tolerance (IGT) and from IGT to diabetes. RESEARCH DESIGN AND METHODS: Insulin-stimulated glucose disposal (M) (hyperinsulinemic clamp), acute insulin secretory response (AIR) (25-g intravenous glucose tolerance test), and body composition (hydrodensitometry or dual-energy X-ray absorptiometry) were measured in 254 Pima Indians with NGT and in 145 Pima Indians with IGT, who were then followed for 0.5-13 years.
RESULTS: After follow-ups of 4.4 +/- 3.1 and 5.5 +/- 3.4 years, 79 (31%) of the subjects with initial NGT had developed IGT, and 64 (44%) of the subjects with initial IGT had developed diabetes. In proportional-hazards analyses with adjustment for age, sex, and percent body fat, low M and low AIR were independent predictors of both the progression from NGT to IGT (relative hazards [95% CI] for 10th vs. 90th percentile: M 2.4 [1.2-4.7], P < 0.02; AIR 2.1 [1.1-4.1], P < 0.04) and from IGT to diabetes (M 2.5 [1.3-5.0], P < 0.01; AIR 1.8 [0.99-3.3], P = 0.055).
CONCLUSIONS: During each stage of the development of type 2 diabetes, insulin resistance and insulin secretory dysfunction are independent predictors of worsening glucose tolerance and are, therefore, both targets for the primary prevention of the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11194248     DOI: 10.2337/diacare.24.1.89

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  95 in total

1.  Impact of family history of diabetes on β-cell function and insulin resistance among Chinese with normal glucose tolerance.

Authors:  Gang Chen; Meizhi Li; Yuan Xu; Nianhui Chen; Huibin Huang; Jixing Liang; Liantao Li; Junping Wen; Lixiang Lin; Jin Yao
Journal:  Diabetes Technol Ther       Date:  2012-03-09       Impact factor: 6.118

2.  A Bayesian population analysis of the development of type 2 diabetes in the offspring of diabetic parents.

Authors:  C W Lin; J H Warram; P Veng-Pedersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-08-11       Impact factor: 2.745

Review 3.  Treatment of prediabetes.

Authors:  Mustafa Kanat; Ralph A DeFronzo; Muhammad A Abdul-Ghani
Journal:  World J Diabetes       Date:  2015-09-25

4.  Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus.

Authors:  Yifei Zhang; Xi Lu; Jie Hong; Menglei Chao; Weiqiong Gu; Weiqing Wang; Guang Ning
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 5.  Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion.

Authors:  Richard E Pratley; Christian Weyer
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

6.  The interplay of insulin resistance and beta-cell dysfunction involves the development of type 2 diabetes in Chinese obeses.

Authors:  Jie Hong; Wei-Qiong Gu; Yi-Fei Zhang; Yi-Sheng Yang; Chun-Fang Shen; Min Xu; Xiao-Ying Li; Wei-Qing Wang; Guang Ning
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

Review 7.  Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation.

Authors:  Maureen M B Schulte; Jui-he Tsai; Kelle H Moley
Journal:  Reprod Sci       Date:  2014-12-07       Impact factor: 3.060

8.  Differences in insulin sensitivity, pancreatic beta cell function and circulating adiponectin across glucose tolerance status in Thai obese and non-obese women.

Authors:  La-Or Chailurkit; Suwannee Chanprasertyothin; Wallaya Jongjaroenprasert; Boonsong Ongphiphadhanakul
Journal:  Endocrine       Date:  2008-04-04       Impact factor: 3.633

9.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

Authors:  Adam G Tabák; Markus Jokela; Tasnime N Akbaraly; Eric J Brunner; Mika Kivimäki; Daniel R Witte
Journal:  Lancet       Date:  2009-06-08       Impact factor: 79.321

10.  Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care.

Authors:  Myrlene A Staten; Michael P Stern; W Greg Miller; Michael W Steffes; Scott E Campbell
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.